Predictive Laboratory Markers for Gastrointestinal Complications in Children with Henoch-Schönlein Purpura

Qin Guo1, Shengying Xia2, Yan Ding3

  • 1Department of General Surgery, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, 430016, People's Republic of China.

Insights

Machine learning identified key lab markers, including neutrophil count and NLR, to predict gastrointestinal complications in Henoch-Schönlein Purpura (HSP) in children. This aids early intervention for better outcomes.

Area of Science:

  • Pediatrics
  • Immunology
  • Medical Diagnostics

Background:

  • Henoch-Schönlein Purpura (HSP) is a prevalent childhood systemic vasculitis.
  • Gastrointestinal system (GIS) involvement is common in HSP.
  • Predictive markers for GIS complications are vital for timely intervention.

Purpose of the Study:

  • To identify laboratory markers that predict GIS complications in pediatric HSP patients.
  • To utilize a machine learning approach for marker identification.

Main Methods:

  • Retrospective study of pediatric HSP patients and controls (May 2020 - Jan 2024).
  • Collected extensive demographic and laboratory data (WBC, neutrophils, platelets, NLR, PLR, etc.).
  • Developed a Random Forest classifier to predict GIS complications.

Main Results:

  • Significant laboratory differences found between HSP patients and controls, and across GIS complication severity.
  • Key predictive markers identified: neutrophil count, NLR, WBC count, PLR, and platelet count.
  • Random Forest model achieved 91% accuracy and 0.90 AUC for predicting GIS complications.

Conclusions:

  • Specific laboratory markers are crucial for predicting GIS complications in pediatric HSP.
  • Machine learning enhances early identification and management of high-risk HSP patients.
  • Improved clinical outcomes are anticipated through early detection and intervention.
Abstract

Related Concept Videos

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
86
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
53
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
307
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
310
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
135